v3.26.1
Condensed Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current Assets:    
Cash $ 767,364
Prepaid expenses 326,967
Total Current Assets 1,094,331
Cash held in Trust 158,441,771
Deferred offering costs 695,255
Total Assets 159,536,102 695,255
Current Liabilities:    
Accrued expenses and offering costs 253,425
Accounts payable 8,000
Related party payable 86,158
Total Current Liabilities 8,000 339,583
Accrued expenses and offering costs - non-current 549,345
Deferred underwriting commission 9,420,000
Total Liabilities 9,977,345 339,583
Commitments and contingencies (Note 6)
Shareholders’ Equity (Deficit):    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital 399,470
Accumulated deficit (8,883,564) (44,328)
Total Shareholders’ Equity (Deficit) (8,883,014) 355,672
Total Liabilities and Shareholders’ Equity (Deficit) 159,536,102 695,255
Class A Ordinary Shares    
Current Liabilities:    
Class A ordinary shares, $0.0001 par value; 15,700,000 shares subject to possible redemption as of June 30, 2026 and 0 as of December 31, 2025 at $10.09 and $0 per share, respectively 158,441,771
Shareholders’ Equity (Deficit):    
Ordinary shares, value 20
Class B Ordinary Shares    
Shareholders’ Equity (Deficit):    
Ordinary shares, value [1],[2] $ 530 $ 530
[1] On May 19, 2026, the underwriter partially exercised the over-allotment option and purchased 700,000 Units, which closed on May 20, 2026. The over-allotment option expired unexercised with respect to the remaining 1,550,000 Units on June 29, 2026, and 516,667 Class B ordinary shares held by the Sponsor were forfeited. Following such forfeiture, the Sponsor holds 5,300,000 Class B ordinary shares (see Note 6).
[2] Shares and associated amounts have been retroactively restated to reflect the surrender for no consideration of 1,916,666 Class B ordinary shares by the Sponsor on May 7, 2026, and the forfeiture of 516,667 Class B ordinary shares by the Sponsor on June 29, 2026.